drugset / Trial / NCT04380298

Effects of Pre-emptive Scalp Infiltration With Low-dose Ketorolac and Ropivacaine for Postoperative Pain

NCT04380298

Phase 4 Unknown 40 enrolled Beijing Tiantan Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

The PAINLESS study is a single-center, prospective, randomized, open-label, blinded-endpoint (PROBE) controlled clinical pilot study to compare the efficacy and safety of pre-emptive scalp infiltration with ropivacaine plus ketorolac and ropivacaine alone for postoperative pain relief in adults undergoing elective supratentorial craniotomies.

Timeline

Start
2020-12-01
Primary completion
2021-07-31
Completion
2021-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified 6 mg Other
Background Epinephrine Other / unclassified 0.1 mg Other
Background Ropivacaine Other / unclassified 60 mg Other

Indications